Dr. Luciano Fusco | Immunology | Best Research Article Award

CONICET y UNNE, Argentina

Author Profile

Orcid 

🎓 Early Academic Pursuits

Dr. Luciano Sebastian Fusco, born on January 2, 1986, in Corrientes, Argentina, has consistently demonstrated a deep passion for science and a commitment to understanding biochemical processes from an early stage in his career. He pursued his foundational studies at the National University of the Northeast (UNNE), where he earned his degree as a Biochemist in 2010. He continued on this academic trajectory, completing a Ph.D. in Chemical Sciences at UNNE in 2015, a decision that marked a turning point in his scientific journey. During this period, Dr. Fusco began his in-depth exploration of snake venom toxicology and immunology—fields that would come to define his career. In addition to his formal degrees, he expanded his academic horizons by completing over 20 specialized postgraduate courses, focusing on immunotoxicology, proteomics, biotechnology, and pedagogical training for higher education, laying a solid foundation for both research and teaching.

🧪 Professional Endeavors

Dr. Fusco currently serves as an Adjunct Researcher at CONICET—Argentina’s most prestigious scientific institution—and as a faculty member at UNNE’s Faculty of Exact and Natural Sciences and Surveying. Over the past 15 years, he has cemented his place as an authority in snakebite toxicology, immunology, and protein chemistry, tackling one of the world’s most neglected tropical diseases. His work combines rigorous laboratory research with practical applications in public health, particularly in developing more effective antivenoms. Dr. Fusco’s scientific career includes strong collaborative links with leading international institutions such as UNICAMP, Fiocruz, and Butantan Institute in Brazil, and the Institute of Biomedicine of Valencia (IBV–CSIC) in Spain. These collaborations have enriched his scientific output and brought global perspectives into his lab in Argentina, positioning him as a bridge between Latin American and European scientific networks.

🔬 Contributions and Research Focus

At the heart of Dr. Fusco’s research is a relentless drive to innovate antivenom production techniques and make them more efficient, affordable, and widely available in regions where snakebites are a major health issue. His projects focus on immunological strategies that incorporate nanostructured adjuvants, aiming to enhance the body’s immune response and increase the efficacy of antivenoms. His groundbreaking investigations have led to the development of experimental antivenoms using novel adjuvants such as CpG-ODN and ascorbyl palmitate, combining cutting-edge immunology with tangible health benefits. He has authored or co-authored more than 15 peer-reviewed publications, contributing significantly to the academic discourse on venom immunogenicity, PLA2 enzyme inhibition, and venom component characterization.

🏅 Accolades and Recognition

Dr. Fusco’s scientific excellence has been consistently recognized through competitive funding and research support from institutions like CONICET, FONCYT, SGCyT, and the Royal Society of Tropical Medicine and Hygiene (RSTMH) in the UK. The RSTMH Early Career Grant he received in 2022 is a testament to his international credibility and the global relevance of his research. These accolades not only reflect the scientific value of his work but also acknowledge his growing leadership in the field of neglected diseases and biomedical innovation.

🌎 Impact and Influence

The societal relevance of Dr. Fusco’s research is profound. In regions such as Latin America, where snakebites are a significant public health burden, his work contributes to saving lives and improving the quality of emergency response systems. By pushing for more immunogenic and affordable antivenoms, he is directly addressing gaps in health equity. Moreover, his dedication to human resource development is notable; he has mentored doctoral students, undergraduate researchers, and research fellows, effectively shaping the next generation of biomedical scientists in Argentina. His interdisciplinary and collaborative approach encourages knowledge sharing across borders, institutions, and cultures.

🌱 Legacy and Future Contributions

Looking forward, Dr. Luciano Fusco is poised to leave a lasting legacy in the realm of immunotherapeutics and venom research. His scientific endeavors will likely continue to evolve, incorporating tools from biotechnology, nanomedicine, and systems biology to refine and revolutionize antivenom production. Equally important is his role as an educator and mentor, ensuring that the future of biochemical research in Argentina remains vibrant and globally connected. His work not only uplifts national scientific capacity but also aligns with global health priorities such as reducing mortality from neglected tropical diseases.

📝Notable Publications

Venomic and F(ab’)₂ antivenomic studies of Bothrops alternatus venom proteins

Author(s): Luciano S. Fusco, Emidio Beraldo-Neto, Juan J. Calvete, Libia Sanz, Laura C. Lanari, Carolina Lorente, Laura C. Leiva, Daniel Pimenta, Adolfo R. de Roodt, Davinia Pla
Journal: International Journal of Biological Macromolecules
Year: 2025

Evaluation of a nanostructured CpG-ODN/ascorbyl palmitate as a safe and effective adjuvant for anticrotalic PLA2 serum

Author(s): Luciano S. Fusco, Gisela L. Lopez, Franco Maslovski, Sofía Brignone, María G. Chaves, Juan J. Calvete, Yanet G. Franco, David Hernandez, Andrea Van de Velde, Constanza Marin et al.
Journal: Transactions of The Royal Society of Tropical Medicine and Hygiene
Year: 2025

 Ascorbyl palmitate (ASC16) as a potential inhibitor of toxicity induced by Crotalus durissus terrificus venom

Author(s): Franco Maslovski, Emilio Angelina, María Alonso, Laura Leiva, Luciano Fusco
Journal: Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Year: 2024

Potential low-impact immunogen for the production of anti-bothropic serum: Bothrops alternatus venom treated with Na₂EDTA

Author(s): Gisela Lumila Lopez, Andrea Van de Velde, David Hernández, Soledad Bustillo, Laura Leiva, Luciano Sebastian Fusco
Journal: Toxicon
Year: 2024

 CpG-ODN formulated with a nanostructure as adjuvant for anticrotalic serum production. Studies in mice

Author(s): Luciano S. Fusco, María M. Pascual, David Hernandez, María F. Sánchez Vallecillo, María B. Arrieta, Gabriel Moron, Santiago Palma, Belkys A. Maletto, Laura C. Leiva
Journal: Toxicon
Year: 2022

Dr. Luciano Fusco | Immunology | Best Research Article Award

You May Also Like